Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study

Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherapeutic, Molecular, and Immune Approaches Aimed at Preventing Relapse

(2009) Michael A. Pulsipher et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Controversies of and Unique Issues in Hematopoietic Cell Transplantation for Infant Leukemia

(2009) Stephen P. Hunger et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options

(2009) D. J. P. M. Stumpel et al.   BLOOD

Evaluation of alternative prognostic stratifications by prediction accuracy measures on individual survival with application to childhood leukaemia

(2009) Paola De Lorenzo et al.   EUROPEAN JOURNAL OF CANCER

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol

(2009) V H J Van der Velden et al.   LEUKEMIA

Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

(2009) H Kreyenberg et al.   LEUKEMIA